相似文献
1
Evolution of the cancer genome.
Trends Genet. 2012 Apr;28(4):155-63. doi: 10.1016/j.tig.2012.01.003. Epub 2012 Feb 16.
2
A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types.
PLoS Comput Biol. 2015 Sep 9;11(9):e1004497. doi: 10.1371/journal.pcbi.1004497. eCollection 2015 Sep.
3
Somatic clonal evolution: A selection-centric perspective.
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):139-150. doi: 10.1016/j.bbcan.2017.01.006. Epub 2017 Feb 2.
4
Characterizing the ecological and evolutionary dynamics of cancer.
Nat Genet. 2020 Aug;52(8):759-767. doi: 10.1038/s41588-020-0668-4. Epub 2020 Jul 27.
5
Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.
Prog Biophys Mol Biol. 2012 Sep;110(1):69-86. doi: 10.1016/j.pbiomolbio.2012.05.001. Epub 2012 May 11.
6
Genome chaos: Creating new genomic information essential for cancer macroevolution.
Semin Cancer Biol. 2022 Jun;81:160-175. doi: 10.1016/j.semcancer.2020.11.003. Epub 2020 Nov 13.
7
Epigenetic inheritance and plasticity: The responsive germline.
Prog Biophys Mol Biol. 2013 Apr;111(2-3):99-107. doi: 10.1016/j.pbiomolbio.2012.08.014. Epub 2012 Sep 4.
8
The origin of novel traits in cancer.
Trends Cancer. 2024 Oct;10(10):880-892. doi: 10.1016/j.trecan.2024.07.005. Epub 2024 Aug 6.
9
Mutation and epigenetic molecular clocks in cancer.
Carcinogenesis. 2011 Feb;32(2):123-8. doi: 10.1093/carcin/bgq239. Epub 2010 Nov 12.
10
Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799.
引用本文的文献
1
Tumor infiltration therapy: from FDA approval to next-generation approaches.
Clin Exp Med. 2025 Jul 18;25(1):254. doi: 10.1007/s10238-025-01574-6.
2
Liquid-liquid phase separation drives immune signaling transduction in cancer: a bibliometric and visualized study from 1992 to 2024.
Front Oncol. 2025 Mar 4;15:1509457. doi: 10.3389/fonc.2025.1509457. eCollection 2025.
3
Emerging Gene-editing nano-therapeutics for Cancer.
Heliyon. 2024 Oct 20;10(21):e39323. doi: 10.1016/j.heliyon.2024.e39323. eCollection 2024 Nov 15.
4
Nanomedicines Targeting Tumor Cells or Tumor-Associated Macrophages for Combinatorial Cancer Photodynamic Therapy and Immunotherapy: Strategies and Influencing Factors.
Int J Nanomedicine. 2024 Oct 4;19:10129-10144. doi: 10.2147/IJN.S466315. eCollection 2024.
5
Systematic review on the role of the gut microbiota in tumors and their treatment.
Front Endocrinol (Lausanne). 2024 Aug 8;15:1355387. doi: 10.3389/fendo.2024.1355387. eCollection 2024.
6
Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
J Cancer Res Clin Oncol. 2024 May 7;150(5):240. doi: 10.1007/s00432-024-05779-2.
7
Association of graph-based spatial features with overall survival status of glioblastoma patients.
Sci Rep. 2023 Oct 9;13(1):17046. doi: 10.1038/s41598-023-44353-7.
8
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
Int J Nanomedicine. 2023 Sep 29;18:5531-5559. doi: 10.2147/IJN.S424872. eCollection 2023.
9
SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric Cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Int J Mol Sci. 2023 Jul 24;24(14):11870. doi: 10.3390/ijms241411870.
10
Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically.
J Pharm Anal. 2023 Jun;13(6):603-615. doi: 10.1016/j.jpha.2023.04.017. Epub 2023 Apr 28.
本文引用的文献
1
Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.
Cancer Cell. 2011 Dec 13;20(6):810-7. doi: 10.1016/j.ccr.2011.11.005. Epub 2011 Dec 1.
2
DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes.
Nat Biotechnol. 2011 Nov 20;29(12):1103-8. doi: 10.1038/nbt.2030.
3
High order chromatin architecture shapes the landscape of chromosomal alterations in cancer.
Nat Biotechnol. 2011 Nov 20;29(12):1109-13. doi: 10.1038/nbt.2049.
4
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Nat Genet. 2011 Oct 30;43(12):1210-4. doi: 10.1038/ng.985.
5
A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1.
Nat Genet. 2011 Oct 30;43(12):1215-8. doi: 10.1038/ng.978.
6
Somatic retrotransposition alters the genetic landscape of the human brain.
Nature. 2011 Oct 30;479(7374):534-7. doi: 10.1038/nature10531.
7
An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.
Cell. 2011 Oct 14;147(2):370-81. doi: 10.1016/j.cell.2011.09.041.
8
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
Cell. 2011 Oct 14;147(2):344-57. doi: 10.1016/j.cell.2011.09.029.
9
Genome sequencing reveals insights into physiology and longevity of the naked mole rat.
Nature. 2011 Oct 12;479(7372):223-7. doi: 10.1038/nature10533.
10
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.
Nat Genet. 2011 Oct 9;43(11):1114-8. doi: 10.1038/ng.958.
Zotero 插件